The Maharashtra Food and Drug Administration (FDA) has intensified its crackdown on Ayurvedic drug manufacturers, permanently cancelling the licences of 10 companies after inspections uncovered serious violations that could compromise the quality, safety and efficacy of medicines.

Statewide drive

The statewide inspection drive covered all 434 licensed Ayurvedic drug manufacturing units in Maharashtra. While 135 manufacturers were issued show-cause notices for non-compliance, grave violations were found at 10 units, prompting the licensing authority to permanently cancel their manufacturing licences.